E. A. Safianik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E. A. Safianik has a total of 135 co-authors. Here are the top co-authors by number of shared publications:
- Nadezhda V. Izmozherova
Ural State Medical University
4 shared publications - Anna A Vikhareva
Ural State Medical University
3 shared publications - Artem Anatolievich Popov
Ural State Medical University; Institute of High-Temperature Electrochemistry of the Ural Branch of the Russian Academy of Sciences
3 shared publications - Olesya Anatolievna Rubanenko
Samara State Medical University
3 shared publications - Tatiana I. Batluk
Association "Eurasian Association of Therapists
3 shared publications - A. A. Kaznina
Privolzhsky Research Medical University
2 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (4) , 6424
Incidence of chronic obstructive pulmonary disease in the newly diagnosed microalbuminuria population: retrospective analysis of the AURA registry database
Aim. To analyze the phenotypes of patients at highest risk for albuminuria (AU) in a population of patients without diabetes and to estimate its prevalence in the identified phenotypes. Material and methods. A total of 4580 patients over 40 years of age without type 1 or 2 diabetes, who had not previously been diagnosed with chronic kidney disease, were included in a real-world practice registry of AU detection in patients with previously undiagnosed CKD — AURA. The registry design did not include patient follow-up. AU was determined using sensitive micral-test strips, with an AU cutoff of 20 mg/L. Results. AU ≥20 mg/L was present in 64,9% of cases. According to univariate analysis, patients with AU compared with those without it were more likely to have the following risk factors: hypertension (79% vs 71,5%), male sex (44,2% vs 38,6%), smoking (31% vs 25,2%), metabolic syndrome (32% vs 23,4%), as well as diseases such as coronary artery disease (35,5% vs 29,7%), heart failure (41,5% vs 35%), atrial fibrillation (17,3% vs 12,5%), prediabetes (14,7% vs 8,9%), chronic obstructive pulmonary disease (COPD) (7,67% vs 3,76%), chronic cystitis (5,35% vs 3,49%). A multivariate model revealed that age (with each 1-year increase in age, the risk of AU increased by 2%, p-value Conclusion. A multivariate analysis of AURA registry data confirmed that AU is independently associated with conditions such as post-infarction cardiosclerosis, atrial fibrillation, prediabetes, metabolic syndrome, chronic cystitis, and COPD. Of particular interest is the study and follow-up of patients with COPD, in whom AU was found in 78,9%.
- 4 June 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (4) , 6424
Open AccessIncidence of chronic obstructive pulmonary disease in the newly diagnosed microalbuminuria population: retrospective analysis of the AURA registry database
Aim. To analyze the phenotypes of patients at highest risk for albuminuria (AU) in a population of patients without diabetes and to estimate its prevalence in the identified phenotypes. Material and methods. A total of 4580 patients over 40 years of age without type 1 or 2 diabetes, who had not previously been diagnosed with chronic kidney disease, were included in a real-world practice registry of AU detection in patients with previously undiagnosed CKD — AURA. The registry design did not include patient follow-up. AU was determined using sensitive micral-test strips, with an AU cutoff of 20 mg/L. Results. AU ≥20 mg/L was present in 64,9% of cases. According to univariate analysis, patients with AU compared with those without it were more likely to have the following risk factors: hypertension (79% vs 71,5%), male sex (44,2% vs 38,6%), smoking (31% vs 25,2%), metabolic syndrome (32% vs 23,4%), as well as diseases such as coronary artery disease (35,5% vs 29,7%), heart failure (41,5% vs 35%), atrial fibrillation (17,3% vs 12,5%), prediabetes (14,7% vs 8,9%), chronic obstructive pulmonary disease (COPD) (7,67% vs 3,76%), chronic cystitis (5,35% vs 3,49%). A multivariate model revealed that age (with each 1-year increase in age, the risk of AU increased by 2%, p-value Conclusion. A multivariate analysis of AURA registry data confirmed that AU is independently associated with conditions such as post-infarction cardiosclerosis, atrial fibrillation, prediabetes, metabolic syndrome, chronic cystitis, and COPD. Of particular interest is the study and follow-up of patients with COPD, in whom AU was found in 78,9%.
- Open Access
- 29 August 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (7) , 5926
Analysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease)
Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of markers (albuminuria (AU), decreased glomerular filtration rate (GFR)) and the prevalence of chronic kidney disease (CKD), which will provide information on the actual detection rate of CKD and the related markers in territories included in the registry of research centers.Material and methods. The article presents the first data from the AURA registry. Recruitment was carried out from March 6, 2023 to January 23, 2024. Thirty-four research centers in various federal districts of the Russian Federation and 104 doctors took part in the recruitment. We included 4580 subjects over the age of 40 years who had no previously established diagnosis of CKD and did not have type 1 or type 2 diabetes. During recruitment, the researchers were guided by the AURA study protocol (Version 1.7/12-26-2022).Results. AU more than 20 mg/g was detected in 64,9% of cases. At the same time, AU is more common at GFR values that may correspond to stage 3A of CKD. The rarer occurrence of AU in those examined with GFR >60 ml/min/1,73 m2 may be explained by less severe renal damage at this CKD stage. The incidence of AU was significantly higher in men, older people, smokers, people with metabolic syndrome, hypertension (HTN), prediabetes and overweight. The occurrence of AU also increased as HTN grade increased. AU detection rate was associated with hypertriglyceridemia, a high blood level of C-reactive protein, which is an integrative marker of inflammation that negatively affects cardiovascular risk.Conclusion. The presented first data from the AURA registry demonstrated the high AU prevalence in people over 40 years of age. A high incidence of AU was typical for patients with HTN, coronary artery disease, atrial fibrillation, heart failure, and prediabetes. An association has been demonstrated between the high incidence of AU and male sex, age, overweight, hyperuricemia, dyslipidemia, and a number of other cardiovascular risk factors.
- 29 August 2024
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 29 (7) , 5926
Open AccessAnalysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease)
Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of markers (albuminuria (AU), decreased glomerular filtration rate (GFR)) and the prevalence of chronic kidney disease (CKD), which will provide information on the actual detection rate of CKD and the related markers in territories included in the registry of research centers.Material and methods. The article presents the first data from the AURA registry. Recruitment was carried out from March 6, 2023 to January 23, 2024. Thirty-four research centers in various federal districts of the Russian Federation and 104 doctors took part in the recruitment. We included 4580 subjects over the age of 40 years who had no previously established diagnosis of CKD and did not have type 1 or type 2 diabetes. During recruitment, the researchers were guided by the AURA study protocol (Version 1.7/12-26-2022).Results. AU more than 20 mg/g was detected in 64,9% of cases. At the same time, AU is more common at GFR values that may correspond to stage 3A of CKD. The rarer occurrence of AU in those examined with GFR >60 ml/min/1,73 m2 may be explained by less severe renal damage at this CKD stage. The incidence of AU was significantly higher in men, older people, smokers, people with metabolic syndrome, hypertension (HTN), prediabetes and overweight. The occurrence of AU also increased as HTN grade increased. AU detection rate was associated with hypertriglyceridemia, a high blood level of C-reactive protein, which is an integrative marker of inflammation that negatively affects cardiovascular risk.Conclusion. The presented first data from the AURA registry demonstrated the high AU prevalence in people over 40 years of age. A high incidence of AU was typical for patients with HTN, coronary artery disease, atrial fibrillation, heart failure, and prediabetes. An association has been demonstrated between the high incidence of AU and male sex, age, overweight, hyperuricemia, dyslipidemia, and a number of other cardiovascular risk factors.
- Open Access
- 22 May 2023
- Published by Endocrinology Research Centre in Obesity and metabolism
- Vol. 20 (1) , 4-12
Metabolic syndrome components and vitamin D availability relationship in late postmenopausal women
BACKGROUND: The global prevalence of vitamin D deficiency is currently a real threat due to association with major chronic non-communicable diseases. Abdominal obesity, hypertension, dyslipidemia, and hyperglycemia contribute significantly to cardiometabolic risk in late postmenopausal women.AIM: to assess the frequency of deficiency and insufficiency of 25(OH)D in late postmenopausal residents of Yekaterinburg; to establish associations of 25(OH)D serum concentration with components of metabolic syndrome and severity of menopausal symptoms.MATERIALS AND METHODS: During the period from October 2018 to March 2020 145 independently living late postmenopausal residents of Yekaterinburg were enrolled in a cross-sectional study. The following scope of data regarding each of the subjects was collected: complaints and anamnesis, anthropometry, diagnosis of metabolic syndrome, arterial hypertension and diabetes mellitus, assessment of 25 (OH)D level by the ECLIA method, LDL-C, HDL-C levels, serum TG by the enzymatic colorimetric method, as well as the evaluation of the modified menopausal index.RESULTS: Adequate serum level of 25(OH)D was detected in 20.6% patients, insufficiency and deficiency were found in 33.1 and 46.2% cases, respectively. In patients with vitamin D deficiency and insufficiency, the most frequent metabolic syndrome components were arterial hypertension (p=0.02; OR 3.5; CI 1.2–10.6) and abdominal obesity (p=0.03; OR 2.8; CI 1.1–7.2). Vitamin D deficient subjects had significantly lower serum HDL and increased TG levels (p=0.04), compared to the adequately provided 25(OH)D patients. Vitamin D levels were not associated with the severity of menopausal symptoms in late postmenopausal women. Regular daily intake of 400–2000 IU of colecalciferol contributed to higher serum 25(OH)D level.CONCLUSION: a high prevalence of vitamin D deficiency among postmenopausal women of Yekaterinburg was detected. Diagnosis and correction of vitamin D levels are necessary for timely reduction of cardiometabolic risk, primarily due to the potential pleiotropic effects of D-hormone on the renin-angiotensin-aldosterone system, carbohydrate and lipid metabolism.
- 22 May 2023
- Published by Endocrinology Research Centre in Obesity and metabolism
- Vol. 20 (1) , 4-12
Open AccessMetabolic syndrome components and vitamin D availability relationship in late postmenopausal women
BACKGROUND: The global prevalence of vitamin D deficiency is currently a real threat due to association with major chronic non-communicable diseases. Abdominal obesity, hypertension, dyslipidemia, and hyperglycemia contribute significantly to cardiometabolic risk in late postmenopausal women.AIM: to assess the frequency of deficiency and insufficiency of 25(OH)D in late postmenopausal residents of Yekaterinburg; to establish associations of 25(OH)D serum concentration with components of metabolic syndrome and severity of menopausal symptoms.MATERIALS AND METHODS: During the period from October 2018 to March 2020 145 independently living late postmenopausal residents of Yekaterinburg were enrolled in a cross-sectional study. The following scope of data regarding each of the subjects was collected: complaints and anamnesis, anthropometry, diagnosis of metabolic syndrome, arterial hypertension and diabetes mellitus, assessment of 25 (OH)D level by the ECLIA method, LDL-C, HDL-C levels, serum TG by the enzymatic colorimetric method, as well as the evaluation of the modified menopausal index.RESULTS: Adequate serum level of 25(OH)D was detected in 20.6% patients, insufficiency and deficiency were found in 33.1 and 46.2% cases, respectively. In patients with vitamin D deficiency and insufficiency, the most frequent metabolic syndrome components were arterial hypertension (p=0.02; OR 3.5; CI 1.2–10.6) and abdominal obesity (p=0.03; OR 2.8; CI 1.1–7.2). Vitamin D deficient subjects had significantly lower serum HDL and increased TG levels (p=0.04), compared to the adequately provided 25(OH)D patients. Vitamin D levels were not associated with the severity of menopausal symptoms in late postmenopausal women. Regular daily intake of 400–2000 IU of colecalciferol contributed to higher serum 25(OH)D level.CONCLUSION: a high prevalence of vitamin D deficiency among postmenopausal women of Yekaterinburg was detected. Diagnosis and correction of vitamin D levels are necessary for timely reduction of cardiometabolic risk, primarily due to the potential pleiotropic effects of D-hormone on the renin-angiotensin-aldosterone system, carbohydrate and lipid metabolism.
- Open Access
- 24 March 2022
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 21 (1) , 48-56
Clinical and functional characteristics and comorbidity in postmenopausal patients taking low doses of cholecalciferol
Introduction. Vitamin D supplementation has been globally reported to be of paramount importance in treating and preventing a wide range of comorbid diseases in postmenopausal women but population-based screening for 25(OH)D levels is not currently part of recommendations.The aim of the studywas to assess the low doses cholecalciferol supplementation impact on the 25 (OH) D status, clinical and functional status and comorbidity in late postmenopausal residents of Ekaterinburg.Material and methods. During the period from October 2018 to March 2020, 145 independently living postmenopausal residents of Ekaterinburg were enrolled in a cross-sectional study. Two groups were identified: 32 persons of Group 1 reported taking 400-2000 IU per day cholecalciferol during at least 6 months (n = 32) before enrollement and 113 women of Group 2 reported no previous cholecalciferol supplementation. Serum 25(OH)VitD level was assessed by the ECLIA method. Known comorbid conditions were registered. Modified menopausal index (MMI), HADS anxiety and depression scales, short form for quality of life evaluation (SF36), Mini-Mental State Examination (MMSE), hand dynamometry, 6-minute walk test, standing up test and tandem test were performed.Results. Supplementation of 400 to 2000 IU of cholecalciferol during at least 6 months was associated with significantly higher serum 25(OH)D level (p 2= 31.49). Carbohydrate metabolism disorders were significantly less frequent in Group 1 (p = 0.038, χ2= 6.548). In this setting, there were no associations of cholecalciferol supplementation with cognitive function, the severity of menopausal disorders, anxiety and depression, and the quality of life in late postmenopausal patients.Discussion. In general, the results obtained are consistent with the data of previous studies in postmenopausal women, but cannot be extrapolated to the general population.Conclusion. 400 to 2000 IU per day cholecalciferol supplementation for 6 months did not ensure adequate serum vitamin D level in 46.7% late postmenopausal women but was associated with significantly higher serum vitamin D level than in a comparison group.
- 24 March 2022
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 21 (1) , 48-56
Open AccessClinical and functional characteristics and comorbidity in postmenopausal patients taking low doses of cholecalciferol
Introduction. Vitamin D supplementation has been globally reported to be of paramount importance in treating and preventing a wide range of comorbid diseases in postmenopausal women but population-based screening for 25(OH)D levels is not currently part of recommendations.The aim of the studywas to assess the low doses cholecalciferol supplementation impact on the 25 (OH) D status, clinical and functional status and comorbidity in late postmenopausal residents of Ekaterinburg.Material and methods. During the period from October 2018 to March 2020, 145 independently living postmenopausal residents of Ekaterinburg were enrolled in a cross-sectional study. Two groups were identified: 32 persons of Group 1 reported taking 400-2000 IU per day cholecalciferol during at least 6 months (n = 32) before enrollement and 113 women of Group 2 reported no previous cholecalciferol supplementation. Serum 25(OH)VitD level was assessed by the ECLIA method. Known comorbid conditions were registered. Modified menopausal index (MMI), HADS anxiety and depression scales, short form for quality of life evaluation (SF36), Mini-Mental State Examination (MMSE), hand dynamometry, 6-minute walk test, standing up test and tandem test were performed.Results. Supplementation of 400 to 2000 IU of cholecalciferol during at least 6 months was associated with significantly higher serum 25(OH)D level (p 2= 31.49). Carbohydrate metabolism disorders were significantly less frequent in Group 1 (p = 0.038, χ2= 6.548). In this setting, there were no associations of cholecalciferol supplementation with cognitive function, the severity of menopausal disorders, anxiety and depression, and the quality of life in late postmenopausal patients.Discussion. In general, the results obtained are consistent with the data of previous studies in postmenopausal women, but cannot be extrapolated to the general population.Conclusion. 400 to 2000 IU per day cholecalciferol supplementation for 6 months did not ensure adequate serum vitamin D level in 46.7% late postmenopausal women but was associated with significantly higher serum vitamin D level than in a comparison group.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (6)
Issues of catering for students of medical universities in Russia. Results of the first multicenter study
Проведенные локальные исследования демонстрируют высокую распространенность факторов риска развития сердечно-сосудистых заболеваний у студентов медицинских вузов, а также тенденцию к нездоровому питанию (качественный, количественный состав пищи, режим питания). Создание и поддержание условий для сохранения здоровья студентов медицинского вуза является социально значимой задачей ввиду высокой востребованности профессии врача. Настоящая работа призвана обратить внимание на имеющиеся проблемы. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить фактическую организацию питания на учебных базах медицинских университетов и субъективное отношение учащихся к ней. МАТЕРИАЛ И МЕТОДЫ Настоящее исследование является частью первого многоцентрового исследования «Здоровье будущего врача», проводимого в России. К опросу приглашались студенты медицинских университетов очной формы обучения, независимо от факультета и курса. Сбор данных для исследования проведен в 2 этапа. На первом этапе респонденты отвечали на анонимную онлайн-анкету. Форма была доступна для заполнения в период с марта по ноябрь 2021 г. включительно. На втором этапе сбора данных координаторы посетили предприятия общественного питания, расположенные в медицинских университетах, с фиксацией наблюдений в чек-листе. Методологической основой для разработки чек-листа стал опросник Nutrition Environment Measures Survey. Аудит проведен только в кафе и столовых, расположенных в основных корпусах медицинских университетов, клинические базы в исследование не включены. Полученные данные систематизированы с помощью Google Forms и MS Excel. Всего в исследовании приняли участие 11 вузов из 10 городов России. Общее число участников составило 2321. Средний возраст опрошенных — 21 год. РЕЗУЛЬТАТЫ Большинство (66,9%) респондентов сообщили, что в кафе и столовых созданы условия для разогревания пищи, принесенной из дома, указанные данные подтверждены при аудите предприятий общественного питания координаторами центров. Достаточной для приема горячей пищи продолжительность перерыва назвали 57%. Оптимальным диапазон работы кафе и столовых считают 69,4% студентов, «часто» отказывались от приема пищи 42,6% учащихся ввиду большой очереди в столовой, 44,5% — по причине отсутствия в кафе здоровых продуктов. Наличие в меню свежих овощей и фруктов отрицают 60,6% студентов, молочных продуктов без добавленного сахара (творог, кефир, ряженка) — 71,9% респондентов. Избыточную массу тела по итогам опроса имеют 15% будущих врачей, а 29,7% заявляют о наличии у них заболевания желудочно-кишечного тракта, необходимости соблюдения режима питания и контроля качественного состава принимаемой пищи. ВЫВОДЫ Полученные результаты демонстрируют, что имеется системная проблема в организации питания будущих врачей. С учетом данных настоящего исследования можно сформулировать ряд предложений по улучшению питания студентов: контроль реализуемой в вузах продукции с отказом от продуктов категории «фастфуд», введение в ассортимент буфетов и столовых молочной продукции без сахара, свежих фруктов и овощей, а также формирование комплексных обедов по принципу «здоровая тарелка» для повышения пропускной способности мест общественного питания.
- 1 January 2022
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 25 (6)
Issues of catering for students of medical universities in Russia. Results of the first multicenter study
Проведенные локальные исследования демонстрируют высокую распространенность факторов риска развития сердечно-сосудистых заболеваний у студентов медицинских вузов, а также тенденцию к нездоровому питанию (качественный, количественный состав пищи, режим питания). Создание и поддержание условий для сохранения здоровья студентов медицинского вуза является социально значимой задачей ввиду высокой востребованности профессии врача. Настоящая работа призвана обратить внимание на имеющиеся проблемы. ЦЕЛЬ ИССЛЕДОВАНИЯ Оценить фактическую организацию питания на учебных базах медицинских университетов и субъективное отношение учащихся к ней. МАТЕРИАЛ И МЕТОДЫ Настоящее исследование является частью первого многоцентрового исследования «Здоровье будущего врача», проводимого в России. К опросу приглашались студенты медицинских университетов очной формы обучения, независимо от факультета и курса. Сбор данных для исследования проведен в 2 этапа. На первом этапе респонденты отвечали на анонимную онлайн-анкету. Форма была доступна для заполнения в период с марта по ноябрь 2021 г. включительно. На втором этапе сбора данных координаторы посетили предприятия общественного питания, расположенные в медицинских университетах, с фиксацией наблюдений в чек-листе. Методологической основой для разработки чек-листа стал опросник Nutrition Environment Measures Survey. Аудит проведен только в кафе и столовых, расположенных в основных корпусах медицинских университетов, клинические базы в исследование не включены. Полученные данные систематизированы с помощью Google Forms и MS Excel. Всего в исследовании приняли участие 11 вузов из 10 городов России. Общее число участников составило 2321. Средний возраст опрошенных — 21 год. РЕЗУЛЬТАТЫ Большинство (66,9%) респондентов сообщили, что в кафе и столовых созданы условия для разогревания пищи, принесенной из дома, указанные данные подтверждены при аудите предприятий общественного питания координаторами центров. Достаточной для приема горячей пищи продолжительность перерыва назвали 57%. Оптимальным диапазон работы кафе и столовых считают 69,4% студентов, «часто» отказывались от приема пищи 42,6% учащихся ввиду большой очереди в столовой, 44,5% — по причине отсутствия в кафе здоровых продуктов. Наличие в меню свежих овощей и фруктов отрицают 60,6% студентов, молочных продуктов без добавленного сахара (творог, кефир, ряженка) — 71,9% респондентов. Избыточную массу тела по итогам опроса имеют 15% будущих врачей, а 29,7% заявляют о наличии у них заболевания желудочно-кишечного тракта, необходимости соблюдения режима питания и контроля качественного состава принимаемой пищи. ВЫВОДЫ Полученные результаты демонстрируют, что имеется системная проблема в организации питания будущих врачей. С учетом данных настоящего исследования можно сформулировать ряд предложений по улучшению питания студентов: контроль реализуемой в вузах продукции с отказом от продуктов категории «фастфуд», введение в ассортимент буфетов и столовых молочной продукции без сахара, свежих фруктов и овощей, а также формирование комплексных обедов по принципу «здоровая тарелка» для повышения пропускной способности мест общественного питания.
- Open Access
- 4 November 2021
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 15 (5) , 515-524
Menopausal hormone therapy affects quality of life in multimorbid late postmenopausal women
Aim: to evaluate an impact of menopausal hormone therapy (MHT) on late postmenopausal multimorbid women’s quality of life (QoL).Materials and Methods. 132 late postmenopausal women were enrolled to the study and were divided into two groups: group 1 consisted of 66 subjects with moderate multimorbidity and Charlson Comorbidity Index (CCI) < 3; group 2 (66 patients) had high multimorbidity (CCI ≥ 3). Women receiving or not MHT were subdivided in both groups. SF-36 questionnaire was used to assess QoL, Hospital Anxiety and Depression scale (HADS) – for evaluating emotional status, MMSE test (Mini-Mental State Examination) – for cognition evaluation. Modified Menopausal Index (MMI) was calculated as well.Results. Women with a low level of comorbidity who had previously received MHT have a significantly higher QoL. The median age for subjects was 69 [65; 71] years, median CCI score was 3.5 [2.5; 5.0]. In addition, in group 2 there were found significantly lower physical functioning (p < 0.001), role-physical functioning (p = 0.028), physical health (p = 0.002) domains, as well as more severe persistent menopausal symptoms (p = 0.011) and depression (p = 0.043). History of MHT in group 1 was associated with higher levels of physical functioning (p = 0.033) and role-physical functioning (p = 0.023), whereas in group 2 MHT was associated with better cognition (p = 0.028) and lower depression symptoms compared with those lacking history of MHT.Conclusion. Multimorbidity in late postmenopausal women was associated with impaired QoL physical domains. MHT allows to effectively improve QoL in women with moderate multimorbidity and to protect cognitive state to higher level as well as reduce depression symptoms in women with severe multimorbidity.
- 4 November 2021
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
- Vol. 15 (5) , 515-524
Open AccessMenopausal hormone therapy affects quality of life in multimorbid late postmenopausal women
Aim: to evaluate an impact of menopausal hormone therapy (MHT) on late postmenopausal multimorbid women’s quality of life (QoL).Materials and Methods. 132 late postmenopausal women were enrolled to the study and were divided into two groups: group 1 consisted of 66 subjects with moderate multimorbidity and Charlson Comorbidity Index (CCI) < 3; group 2 (66 patients) had high multimorbidity (CCI ≥ 3). Women receiving or not MHT were subdivided in both groups. SF-36 questionnaire was used to assess QoL, Hospital Anxiety and Depression scale (HADS) – for evaluating emotional status, MMSE test (Mini-Mental State Examination) – for cognition evaluation. Modified Menopausal Index (MMI) was calculated as well.Results. Women with a low level of comorbidity who had previously received MHT have a significantly higher QoL. The median age for subjects was 69 [65; 71] years, median CCI score was 3.5 [2.5; 5.0]. In addition, in group 2 there were found significantly lower physical functioning (p < 0.001), role-physical functioning (p = 0.028), physical health (p = 0.002) domains, as well as more severe persistent menopausal symptoms (p = 0.011) and depression (p = 0.043). History of MHT in group 1 was associated with higher levels of physical functioning (p = 0.033) and role-physical functioning (p = 0.023), whereas in group 2 MHT was associated with better cognition (p = 0.028) and lower depression symptoms compared with those lacking history of MHT.Conclusion. Multimorbidity in late postmenopausal women was associated with impaired QoL physical domains. MHT allows to effectively improve QoL in women with moderate multimorbidity and to protect cognitive state to higher level as well as reduce depression symptoms in women with severe multimorbidity.